Wolverine Trading’s Krystal Biotech KRYS Stock Holding History

Wolverine Trading’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.83M	Buy	16,000 +13,400	+515%	+$2.01M	﹤0.01%	1869
2025 Q2	$361K	Sell	2,600 -4,800	-65%	-$705K	﹤0.01%	3275
2025 Q1	$1.36M	Buy	7,400 +3,100	+72%	+$521K	﹤0.01%	1965
2024 Q4	$687K	Sell	4,300 -500	-10%	-$88.7K	﹤0.01%	3048
2024 Q3	$850K	Buy	+4,800	New	+$926K	﹤0.01%	2520
2023 Q4	–	Sell	-2,700	Closed	-$313K	–	4869
2023 Q3	$313K	Sell	2,700 -300	-10%	-$36.6K	﹤0.01%	3251
2023 Q2	$347K	Buy	+3,000	New	+$306K	﹤0.01%	2939
2023 Q1	–	Sell	-4,200	Closed	-$333K	–	4605
2022 Q4	$333K	Buy	+4,200	New	+$312K	﹤0.01%	2677
2021 Q3	–	Sell	-3,000	Closed	-$207K	–	6620
2021 Q2	$207K	Buy	+3,000	New	+$209K	﹤0.01%	4977

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Trading's KRYS Position: Q3 2025 in Review

Wolverine Trading opened a new position in Krystal Biotech (KRYS) in Q3 2025: 2,154 shares worth $381K. The stake represents ﹤0.01% of the portfolio and ranks #4037 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in KRYS as recently as Q3 2024.

Wolverine Trading first reported a position in KRYS in Q2 2023 and has held it in 4 quarters since. 284 funds tracked by Wall St. Rank hold KRYS as of Q3 2025.

Wolverine Trading held 2,154 shares of Krystal Biotech worth $381K as of Q3 2025.
Krystal Biotech was a new Wolverine Trading position in Q3 2025.
Krystal Biotech made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4037 holding.
Wolverine Trading first reported a position in Krystal Biotech in Q2 2023 and has held it in 4 quarters since.
284 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.